dubarachnoid hemorragh - Nursing Case Study
Pathophysiology
• Primary mechanism: A subarachnoid hemorrhage (SAH) occurs when a blood vessel on the brain's surface ruptures, releasing blood into the subarachnoid space. This is often due to a ruptured cerebral aneurysm, which leads to increased intracranial pressure and potential brain damage.
• Secondary mechanism: The presence of blood in the subarachnoid space can cause irritation and inflammation of the meninges, leading to vasospasm. Vasospasm narrows the cerebral arteries, reducing blood flow and potentially causing ischemia and further neuronal injury.
• Key complication: Cerebral vasospasm can result in delayed cerebral ischemia, a significant cause of morbidity and mortality post-SAH. Monitoring and managing this is crucial in nursing care to prevent secondary brain injury.
Patient Profile
Demographics:
45-year-old female, office manager
History:
• Key past medical history: Hypertension, type 2 diabetes
• Current medications: Lisinopril, Metformin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sudden severe headache
• Key symptoms: Nausea, neck stiffness, photophobia
• Vital signs: Blood pressure 160/100 mmHg, heart rate 98 bpm, respiratory rate 22 breaths/min, temperature 37.8°C
Section 1
As the medical team continues to monitor the patient following her initial presentation with a subarachnoid hemorrhage, a new complication arises. During the second day of hospitalization, the patient begins to exhibit signs of increased neurological impairment. Her Glasgow Coma Scale score, initially recorded as 15, now decreases to 12, indicating a decrease in her level of consciousness. The patient shows increased confusion and disorientation, and her speech becomes slurred. These changes prompt an immediate re-evaluation of her condition.
The nursing staff promptly notifies the attending physician, and a repeat CT scan of the brain is ordered. The new imaging reveals evidence of cerebral vasospasm, a common complication in the days following a subarachnoid hemorrhage. The vasospasm results in narrowed cerebral vessels, reducing blood flow to critical areas of the brain, which correlates with her declining neurological status. Laboratory tests show a slight increase in white blood cell count, indicative of the inflammatory response associated with the presence of blood in the subarachnoid space. Furthermore, her blood pressure remains elevated, with recent readings averaging 165/105 mmHg, complicating the management of cerebral perfusion.
In response to these findings, the treatment plan is adjusted to address the vasospasm and prevent further ischemic injury. Nimodipine, a calcium channel blocker, is initiated to mitigate the effects of vasospasm and improve cerebral blood flow. The nursing team implements frequent neurological assessments and continues to monitor vital signs closely, particularly focusing on maintaining optimal blood pressure to support cerebral perfusion. These interventions aim to stabilize the patient's condition and prevent further deterioration, highlighting the need for vigilant monitoring and timely adjustment of therapeutic strategies in managing subarachnoid hemorrhage and its complications.
Section 2
As the treatment for cerebral vasospasm is underway, the patient initially shows signs of stabilization. However, on the fourth day of hospitalization, a new complication arises. During a routine neurological assessment, the nursing staff observes that the patient's right pupil is now slightly larger than the left and reacts sluggishly to light. Additionally, the patient reports a sudden, severe headache, worse than any she had experienced since the onset of her subarachnoid hemorrhage. Her blood pressure is noted to be 170/110 mmHg despite ongoing management, and her heart rate has increased to 105 beats per minute. The nursing team promptly communicates these findings to the attending physician.
In response to these alarming changes, a prompt CT angiogram is performed, revealing new developments. The imaging shows an increase in the severity of the cerebral vasospasm, particularly affecting the branches of the middle cerebral artery. Furthermore, there is evidence of a small, new area of ischemia in the left temporal lobe, likely due to reduced perfusion. This finding correlates with the patient's increased neurological impairment and suggests that the current interventions are insufficient to fully address the cerebral blood flow issues.
Given these developments, the medical team revises the treatment strategy. In addition to continuing nimodipine, they consider endovascular intervention to mechanically dilate the affected vessels and improve cerebral perfusion. The patient is placed under intensive monitoring, with an emphasis on vigilant neurological assessments and managing blood pressure meticulously to prevent further ischemic complications. These changes illustrate the complexity of managing subarachnoid hemorrhage and its complications, underscoring the need for adaptive clinical reasoning and a proactive approach in handling emerging challenges.
Section 3
Following the revised treatment strategy, the patient undergoes endovascular intervention to address the worsening cerebral vasospasm. The procedure involves the use of balloon angioplasty to mechanically dilate the constricted vessels and improve blood flow to the ischemic areas. Post-intervention, the patient is closely monitored in the intensive care unit for any changes in neurological status and hemodynamic stability.
On the day following the procedure, nursing staff conducts a thorough neurological assessment and notes some positive changes. The patient's pupillary response has improved, with both pupils now equal in size and reacting briskly to light. Additionally, the patient reports a slight reduction in headache intensity, although it remains present. Her blood pressure has decreased to 150/90 mmHg, and her heart rate has stabilized at 95 beats per minute. These findings suggest a partial improvement in cerebral perfusion and a positive initial response to the endovascular treatment.
Despite these encouraging signs, the patient begins to exhibit new complications. Later in the evening, she becomes increasingly restless and confused, struggling to follow simple commands. Her confusion is accompanied by a mild fever of 38.2°C (100.8°F), raising concerns about the possibility of an infectious process. Blood cultures and a lumbar puncture are ordered to rule out meningitis or other infections. Concurrently, a repeat CT scan is scheduled to assess for any new hemorrhagic or ischemic changes in the brain. This development prompts the healthcare team to apply clinical reasoning to differentiate between potential causes of the altered mental status, considering both infectious and neurological etiologies. The unfolding scenario underscores the dynamic nature of patient care in cases of subarachnoid hemorrhage, highlighting the necessity for ongoing assessment and adaptive management strategies.
Section 4
New Diagnostic Results:
The following morning, the diagnostic tests return with crucial insights into the patient's condition. The blood cultures are negative, ruling out a systemic infection, but the lumbar puncture reveals a slight elevation in white blood cell count and protein levels in the cerebrospinal fluid. These findings suggest an inflammatory response, which may be secondary to the recent hemorrhage rather than an outright infection. The repeat CT scan, however, indicates a small area of low density in the frontal lobe, suggesting possible early ischemic changes due to ongoing cerebral vasospasm, despite the recent intervention.
With these results, the healthcare team must exercise clinical reasoning to determine the next steps. The presence of ischemic changes, coupled with the patient’s neurological decline, indicates that the vasospasm may still be affecting cerebral perfusion. The team considers adjusting the patient's management plan, potentially including the administration of calcium channel blockers to further manage the vasospasm and improve blood flow to the affected areas. Additionally, the mild fever and inflammatory markers may necessitate the use of anti-inflammatory medications to mitigate any secondary inflammatory processes that could be exacerbating her symptoms.
As the patient continues to be monitored, her vital signs remain stable with a blood pressure of 148/88 mmHg and a heart rate of 92 beats per minute, but her confusion persists. This development emphasizes the need for a multidisciplinary approach, incorporating neurology, infectious disease, and critical care teams to address the complex interplay of factors influencing her recovery. The team remains vigilant, prepared to pivot their strategy as new information becomes available, highlighting the importance of adaptive management in the care of patients with subarachnoid hemorrhage.
Section 5
As the day progresses, the patient exhibits a change in her status, presenting new complications that warrant immediate attention. Her confusion has intensified, and she now exhibits signs of expressive aphasia, struggling to form coherent sentences. A focused neurological assessment reveals a slight right-sided weakness, particularly noticeable in her grip strength and toe dorsiflexion. Her vital signs remain stable, but the newly developed neurological deficits suggest worsening cerebral ischemia or the potential for another vascular event.
The healthcare team promptly orders a repeat CT angiography to assess for any progression of vasospasm or new developments such as a re-bleed or an expanding hematoma. The scan results show pronounced vasospasm in the middle cerebral artery, correlating with the ischemic changes seen in the frontal lobe. Additionally, there is evidence of increased cerebral edema, likely contributing to her neurological decline. Recognizing the urgency, the team intensifies the patient's management by initiating high-dose calcium channel blockers and increasing fluid therapy to maintain adequate cerebral perfusion and counteract the vasospasm.
In parallel, the multidisciplinary team convenes to evaluate the potential need for further intervention, such as endovascular therapy, to address the persistent vasospasm. They also consider escalating anti-inflammatory treatment to reduce the cerebral edema. As these interventions are implemented, close monitoring of the patient's neurological status and hemodynamics is paramount to assess her response and adjust the treatment plan as needed. This proactive and adaptive approach underscores the complexity of managing subarachnoid hemorrhage and the importance of timely, coordinated care in mitigating complications and optimizing patient outcomes.